Pfizer Clinical Research Unit

The Pfizer Clinical Research Unit in Brussels conducts studies focused on heart failure and hypertension, aiming to evaluate new treatments that improve cardiac function and blood pressure control.

• Heart Failure
• Primary and secondary hypertension
• Transthyretin amyloidosis (cardiac involvement)
• Cardiovascular safety assessments

These trials seek to advance therapeutic options for patients with cardiovascular conditions and reduce disease burden.

Research at the site includes ER+/HER2 negative breast cancer, small cell lung cancer, and castration-resistant prostate cancer, testing innovative therapies to halt tumor growth.

• Breast Cancer
• Small Cell Lung Cancer
• Castration‑Resistant Prostate Cancer
• Follicular Lymphoma
• Transthyretin amyloidosis

The aim is to improve survival rates and quality of life for patients with various malignancies.

Studies target rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease, evaluating novel immunomodulators that reduce disease activity.

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Inflammatory Bowel Disease
• Ulcerative Colitis
• Immune‑mediated inflammatory disorders

These investigations aim to provide more effective and safer treatment options for autoimmune conditions.

Ongoing research on COVID‑19 and Respiratory Syncytial Virus (RSV) explores antiviral agents and vaccine strategies to prevent infection and improve outcomes.

• COVID‑19 (SARS‑CoV‑2)
• Respiratory Syncytial Virus (RSV)
• Severe acute respiratory syndrome coronavirus 2
• Antiviral drug evaluations

The goal is to enhance public health defenses against emerging and seasonal viral threats.

Trials address type 2 diabetes and obesity, testing new metabolic therapies and lifestyle interventions to improve glycemic control and weight management.

• Type 2 Diabetes Mellitus
• Obesity
• Overweight management
• Metabolic syndrome

These studies aim to reduce the long‑term complications associated with metabolic disorders.

Research includes investigations into growth hormone deficiency and related skeletal conditions, seeking therapies that support bone health and normal growth.

• Growth Hormone Deficiency
• Musculoskeletal disorders
• Bone density abnormalities
• Hormonal regulation studies

The purpose is to develop safe and effective treatments that improve musculoskeletal function and quality of life.